Catalyst

Slingshot members are tracking this event:

Tesaro (TSRO) Expects Launch of VARUBI IV in U.S in Mid-2017 for Chemotherapy-Induced Nausea and Vomiting

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TSRO

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Varubi Iv, Chemotherapy-induced Nausea And Vomiting